SMAD3 and neoplasm: To determine whether methylation-deficient mutants of SMAD3 abrogate tumor metastasis in vivo, we injected SMAD3 WT and SMAD3 K53/333R MDA-MB-231 cells into the tail veins of 4-week-old female BALB/c nude mice.